Drug
Topical Minocycline Foam FXFM244
Topical Minocycline Foam FXFM244 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
3
75%
Ph early_phase_1
1
25%
Phase Distribution
1
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (25.0%)
Phase 23 (75.0%)
Trials by Status
not_yet_recruiting125%
completed250%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingearly_phase_1
Topical Minocycline for CARP
NCT07462702
terminatedphase_2
Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients
NCT01134991
completedphase_2
Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients
NCT01171326
completedphase_2
Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients
NCT01362010
Clinical Trials (4)
Showing 4 of 4 trials
NCT07462702Early Phase 1
Topical Minocycline for CARP
NCT01134991Phase 2
Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients
NCT01171326Phase 2
Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients
NCT01362010Phase 2
Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4